Medility, a pharma tech startup, is pioneering digital transformation in the pharmacy sector with its innovative solutions designed to enhance healthcare operations regardless of size or location. Founded by a pharmacist with 10+ years of experience, Medility aims to address the daily challenges encountered in healthcare systems, enabling healthcare providers to prioritize patient care.
Pilleye, Medility's flagship solution, leverages artificial intelligence to streamline the laborious task of pill counting for pharmacists, ensuring unparalleled accuracy (99.999%) in detecting and counting various types of pills. With more than 410,000 users across 225 countries, Pilleye has saved over 1,260,000 hours for healthcare providers, marking a significant impact on operational efficiency. Medility is dedicated to expanding its digital transformation initiatives to encompass pharmacies, veterinary clinics, hospitals, and beyond.
Founded in 2020 and headquartered in South Korea, Medility recently secured a KRW5.60B Seed Round investment on July 3, 2023, attracting backing from prominent investors including Kakao Ventures, KB Investments, Korea Development Bank, and BA Partners. With its impressive track record, Medility is poised to continue revolutionizing healthcare and pharmacy operations on a global scale.
For further inquiries about Medility, you can reach out to the team at [email protected].